Structural basis for amide hydrolysis catalyzed by the 43C9 antibody

Journal of Molecular Biology

Volumn 291, Issue 2, 1999, Pages 329-345

  Thayer, Maria M ^a   Olender, Eric H ^a   Arvai, Andrew S ^a   Koike, Cami K ^a   Canestrelli, Ilona L ^a   Stewart, Jon D ^b   Benkovic, Stephen J ^c   Getzoff, Elizabeth D ^a   Roberts, Victoria A ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b University of Florida ^*  (United States)

^c PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

Amide hydrolysis; Antibody structure; Antibody antigen interactions; Catalytic antibody; X ray crystallography

Indexed keywords

AMIDE; CATALYTIC ANTIBODY; NITROPHENOL;

ANTIBODY COMBINING SITE; ANTIBODY STRUCTURE; ANTIGEN ANTIBODY REACTION; ARTICLE; COMPLEMENTARITY DETERMINING REGION; CONFORMATION; CRYSTAL STRUCTURE; HYDROGEN BOND; HYDROLYSIS; PRIORITY JOURNAL;

EID: 0032804821     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.1999.2960     Document Type: Article

References (61)

1. Ban N., Escobar C., Garcia R., Hasel K., Day J., Greenwood A., McPherson A. Crystal structure of an idiotype-anti-idiotype Fab complex. Proc. Natl Acad. Sci. USA. 91:1994;1604-1608.
2. Benkovic S. J., Adams J. A., Borders C. L. Jr, Janda K. D., Lerner R. A. The enzymatic nature of antibody catalysis: Development of multistep kinetic processing. Science. 250:1990;1135-1139.
3. Bentley G. A., Boulot G., Riottot M. M., Poljak R. J. Three-dimensional structure of an idiotope-anti-idiotope complex. Nature. 348:1990;254-257.
4. Bernstein F. C., Koetzle T. F., Williams G. J. B., Meyer E. F. Jr, Brice M. D., Rodgers J. R., Kennard O., Shimanouchi T., Tasumi M. The Protein Data Bank: a computer-based archival file for macromolecular structures. J. Mol. Biol. 112:1977;535-542.
5. Braden B. C., Fields B. A., Ysern X., Dall'Acqua W., Goldbaum F. A., Poljak R. J., Mariuzza R. A. Crystal structure of an Fv-Fv idiotope-anti-idiotope complex at 1.9 Å resolution. J. Mol. Biol. 264:1996;137-151.
6. Brinkmann U., Mattes R. E., Buckel P. High-level expression of recombinant genes in Escherichia coli is dependent on the availability of the dnaY gene product. Gene. 85:1989;109-114.
7. Brünger A. T., Kuriyan J., Karplus M. Crystallographic R factor refinement by molecular dynamics. Science. 235:1987;458-460.
8. Buchbinder J. L., Stephenson R. C., Scanlan T. S., Fletterick R. J. A comparison of the crystallographic structures of two catalytic antibodies with esterase activity. J. Mol. Biol. 282:1998;1033-1041.
9. Carter P., Wells J. A. Dissecting the catalytic triad of a serine protease. Nature. 332:1988;564-568.
10. Charbonnier J.-B., Carpenter E., Gigant B., Golinelli-Pimpaneau B., Eshhar Z., Green B. S., Knossow M. Crystal structure of the complex of a catalytic antibody Fab fragment with a transition state analog: Structural similarities in esterase-like catalytic antibodies. Proc. Natl Acad. Sci. USA. 92:1995;11721-11725.
11. Charbonnier J.-B., Golinelli-Pimpaneau B., Gigant B., Tawfik D. S., Chap R., Schindler D. G., Kim S.-H., Green B. S., Eshhar Z., Knossow M. Structural convergence in the active sites of a family of catalytic antibodies. Science. 275:1997;1140-1142.
12. Chien N. C., Roberts V. A., Giusti A. M., Scharff M. D., Getzoff E. D. Significant structural and functional change of an antigen-binding site by a distant amino acid substitution: proposal of a structural mechanism. Proc. Natl Acad. Sci. USA. 86:1989;5532-5536.
13. Chothia C., Lesk A. M. Canonical structures for the hypervariable regions of immunoglobulins. J. Mol. Biol. 196:1987;901-917.
14. Chothia C., Lesk A. M., Tramontano A., Levitt M., Smith-Gill S. J., Air G., Sheriff S., Padlan E. A., Davies D., Tulip W. R., Colman P. M., Spinelli S., Alzari P. M., Poljak R. J. Conformations of immunoglobulin hypervariable regions. Nature. 342:1989;877-883.
15. Corey D. R., Craik C. S. An investigation into the minimum requirements for peptide hydrolysis by mutation of the catalytic triad of trypsin. J. Am. Chem. Soc. 114:1992;1784-1790.
16. Crowder M. W., Stewart J. D., Roberts V. A., Bender C. J., Tevelrakh E., Peisach J., Getzoff E. D., Gaffney B. J., Benkovic S. J. Spectroscopic studies on the designed metal-binding sites of the 43C9 single chain antibody. J. Am. Chem. Soc. 117:1995;5627-5634.
17. Fujii I., Tanaka F., Miyashita H., Tanimura R., Kinoshita K. Correlation between antigen-combining-site structures and functions within a panel of catalytic antibodies generated against a single transition state analog. J. Am. Chem. Soc. 117:1995;6199-6209.
18. Gibbs R. A., Posner B. A., Filpula D. R., Dodd S. W., Finkelman M. A. J., Lee T. K., Wroble M., Whitlow M., Benkovic S. J. Construction and characterization of a single-chain catalytic antibody. Proc. Natl Acad. Sci. USA. 88:1991;4001-4004.
19. Gibbs R. A., Benkovic P. A., Janda K. D., Lerner R. A., Benkovic S. J. Substituent effects on an antibody-catalyzed hydrolysis of phenyl esters: Further evidence for an acyl-antibody intermediate. J. Am. Chem. Soc. 114:1992;3528-3534.
20. Gigant B., Charbonnier J.-B., Eshhar Z., Green B. S., Knossow M. X-ray structures of a hydrolytic antibody and of complexes elucidate catalytic pathway from substrate binding and transition state stabilization through water attack and product release. Proc. Natl Acad. Sci. USA. 94:1997;7857-7861.
21. Golinelli-Pimpaneau B., Gigant B., Bizebard T., Navaza J., Saludjian P., Zemel R., Tawfik D. S., Eshhar Z., Green B. S., Knossow M. Crystal structure of a catalytic antibody Fab with esterase-like activity. Structure. 2:1994;175-183.
22. Guo J., Huang W., Scanlan T. S. Kinetic and mechanistic characterization of an efficient hydrolytic antibody: evidence for the formation of an acyl intermediate. J. Am. Chem. Soc. 116:1994;6062-6069.
23. Guo J., Huang W., Zhou G. W., Fletterick R. J., Scanlan T. S. Mechanistically different catalytic antibodies obtained from immunization with a single transition-state analog. Proc. Natl Acad. Sci. USA. 92:1995;1694-1698.
24. Janda K. D., Schloeder D., Benkovic S. J., Lerner R. A. Induction of an antibody that catalyzes the hydrolysis of an amide bond. Science. 241:1988;1188-1191.
25. Jencks W. P. Catalysis in Chemistry and Enzymology. 1969.
26. Jiang J.-S., Brünger A. T. Protein hydration observed by X-ray diffraction: solvation properties of penicillopepsin and neuraminidase crystal structures. J. Mol. Biol. 243:1994;100-115.
27. Kabat E. A., Wu T. T., Perry H. M., Gottesman K. S., Foeller C. Sequences of Proteins of Immunological Interest. 1991;US Department of Health and Human Services, Washington.
28. Kallen J., Walkinshaw M. D. The X-ray structure of a tetrapeptide bound to the active site of human cyclophilin A. FEBS Letters. 300:1992;286-290.
29. Krebs J. F., Siuzdak G., Dyson H. J., Stewart J. D., Benkovic S. J. Detection of a catalytic antibody species acylated at the active site by electrospray mass spectrometry. Biochemistry. 34:1995;720-723.
30. Kristensen O., Vassylyev D. G., Tanaka F., Morikawa K., Fujii I. A structural basis for transition-state stabilization in antibody-catalyzed hydrolysis: crystal structures of an abzyme at 1.8 Å resolution. J. Mol. Biol. 281:1998;501-511.
31. Laskowski R. A., MacArther M. W., Moss D. S., Thornton J. M. PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Crystallog. 26:1993;283-291.
32. Levitt M., Perutz M. F. Aromatic rings act as hydrogen bond acceptors. J. Mol. Biol. 201:1988;751-754.
33. Liu J., Albers M. W., Chen C.-M., Schreiber S. L., Walsh C. T. Cloning, expression, and purification of human cyclophilin in Escherichia coli and assessment of the catalytic role of cysteines by site-directed mutagenesis. Proc. Natl Acad. Sci. USA. 87:1990;2304-2308.
34. MacBeath G., Hilvert D. Hydrolytic antibodies: variations on a theme. Chem. Biol. 3:1996;433-445.
35. McRee D. E. XtalView: a visual protein crystallographic software system for X11/XView. J. Mol. Graph. 10:1992;44-47.
36. Mian I. S., Bradwell A. R., Olson A. J. Structure, function and properties of antibody binding sites. J. Mol. Biol. 217:1991;133-151.
37. Morea V., Tramontano A., Rustici M., Chothia C., Lesk A. M. Antibody structure, prediction and redesign. Biophys. Chem. 68:1997;9-16.
38. Morea V., Tramontano A., Rustici M., Chothia C., Lesk A. M. Conformations of the third hypervariable region in the VH domain of immunoglobulins. J. Mol. Biol. 275:1998;269-294.
39. Navaza L. AMoRe: an automated package for molecular replacement. Acta Crystallog. sect. A. 50:1994;157-163.
40. Otwinowski Z., Minor W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276:1997;307-326.
41. Patten P. A., Gray N. S., Yang P. L., Marks C. B., Wedemayer G. J., Boniface J. J., Stevens R. C., Schultz P. G. The immunological evolution of catalysis. Science. 271:1996;1086-1091.
42. Read R. J. Improved Fourier coefficients for maps using phases from partial structures with errors. Acta Crystallog. sect. A. 42:1986;140-149.
43. Rini J. M., Schulze-Gahmen U., Wilson I. A. Structural evidence for induced fit as a mechanism for antibody-antigen recognition. Science. 255:1992;959-965.
44. Roberts V. A., Getzoff E. D. Metalloantibody design. FASEB J. 9:1995;94-100.
45. Roberts V. A., Stewart J. D., Benkovic S. J., Getzoff E. D. Catalytic antibody model and mutagenesis implicate arginine in transition-state stabilization. J. Mol. Biol. 235:1994;1098-1116.
46. Rosen M. K., Standaert R. F., Galat A., Nakatsuka M., Schreiber S. L. Inhibition of FKBP rotamase activity by immunosuppressant FK506: Twisted amide surrogate. Science. 248:1990;863-866.
47. Shirai H., Kidera A., Nakamura H. Structural classification of CDR-H3 in antibodies. FEBS Letters. 399:1996;1-8.
48. Stewart J. D., Benkovic S. J. Transition-state stabilization as a measure of the efficiency of antibody catalysis. Nature. 375:1995;388-391.
49. Stewart J. D., Liotta L. J., Benkovic S. J. Reaction mechanisms displayed by catalytic antibodies. Acc. Chem. Res. 26:1993;396-404.
50. Stewart J. D., Krebs J. F., Siuzdak G., Berdis A. J., Smithrud D. B., Benkovic S. J. Dissection of an antibody-catalyzed reaction. Proc. Natl Acad. Sci. USA. 91:1994a;7404-7409.
51. Stewart J. D., Roberts V. A., Crowder M. W., Getzoff E. D., Benkovic S. J. Creation of a novel biosensor for Zn(II). J. Am. Chem. Soc. 116:1994b;415-416.
52. Stewart J. D., Roberts V. A., Thomas N. R., Getzoff E. D., Benkovic S. J. Site-directed mutagenesis of a catalytic antibody: An arginine and a histidine residue play key roles. Biochemistry. 33:1994c;1994-2003.
53. Tawfik D. S., Zemel R. R., Arad-Yellin R., Green B. S., Eshhar Z. Simple method for selecting catalytic monoclonal antibodies that exhibit turnover and specificity. Biochemistry. 29:1990;9916-9921.
54. Tronrud D. E. TNT refinement package. Methods Enzymol. 277:1997;306-319.
55. Tronrud D. E., Ten Eyck L. F., Matthews B. W. An efficient general-purpose least-squares refinement program for macromolecular structures. Acta Crystallog. sect. A. 43:1987;489-501.
56. Upson C., Faulhaber T., Kamins D., Laidlaw D., Schlegel D., Vroom J., Gurwitz R., van Dam A. The application visualization system: a computational environment for scientific visualization. IEEE Comp. Graphics Appl. 9:1989;30-42.
57. Wang Q., Bennet A. J., Brown R. S., Santarsiero B. D. Distorted amides as models for activated peptide N - C=O units. 2. The synthesis, hydrolytic profile, and molecular structure of 3,4-dihydro-2-oxo-1,4-propanoquinoline. Can. J. Chem. 68:1990;1732-1739.
58. Wedemayer G. J., Patten P. A., Wang L. H., Schultz P. G., Stevens R. C. Structural insights into the evolution of an antibody combining site. Science. 276:1997;1665-1669.
59. Wirsching P., Ashley J. A., Benkovic S. J., Janda K. D., Lerner R. A. An unexpectedly efficient catalytic antibody operating by ping-pong and induced fit mechanisms. Science. 252:1991;680-685.
60. Zemel R., Schindler D. G., Tawfik D. S., Eshhar Z., Green B. S. Differences in the biochemical properties of esterolytic antibodies correlate with structural diversity. Mol. Immunol. 31:1994;127-137.
61. Zhou G. W., Guo J., Huang W., Fletterick R. J., Scanlan T. S. Crystal structure of a catalytic antibody with a serine protease active site. Science. 265:1994;1059-1064.